Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
09/2003
09/03/2003EP0988330B1 Method for the preparation of copolymers of ethylene/norbornene-type monomers with nickel catalysts
09/03/2003EP0737209B1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
09/03/2003CN1440416A Catalyst for asymmetric (transfer) hydrogenation
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440393A Cyclic compounds
09/03/2003CN1440375A Secondary C10-18 surfactant alcohols
09/03/2003CN1439643A Spiro-diphosphine ligand
09/02/2003US6613945 2-formyl-3,6-diphenyl-4,5-dimethyl-1-phosphanorborna-2,5-diene reacted with a diol or a diamine; hydrolysis of the acetal
09/02/2003US6613939 Acidifying solution of water soluble sulfonated organophosphorus compounds to reduce concentration of sulfite; compounds useful as two-phase catalysts for carbonylation, hydroformylation, hydrocyanation and isomerization
09/02/2003US6613928 Reacting bisphenol A with a phosphorus oxytrihalide to prepare a phosphorohalidate, reacting that with with a monophenol,
09/02/2003US6613922 Such as (S)-ps-ortho-Bis(bis(dimethylamino)phosphino)-(2.2)-p-cyclophane; useful as chemical intermediates for transition metal-catalysed asymmetric hydrogenation reactions
09/02/2003US6613902 Induce biosynthesis of cytokines such as interferons, interleukins, and tumor necrosis factor in humans and in mice.
09/02/2003US6613848 Phosphorus-containing phenolic, thiophenolic or aminophenyl flame-retardant hardener, and epoxy resins cured thereby
09/02/2003US6613823 Composition formed by combining components comprising polyolefin, arylalkyl diphosphite, second different arylalkyl diphosphite or triarylphosphite, hindered phenol and water
09/02/2003US6613761 (3R,5S)-N- methanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl) -1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4, 1-benzoxazepine-3-acetamide, used as antilipemic agents and enzyme inhibitors
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
09/02/2003US6613717 Phosphoric benzoyl derivatives and their use as herbicides
09/02/2003CA2151543C Immunogens for the production of cocaine-hydrolyzing catalytic antibodies
08/2003
08/28/2003WO2003070736A1 Method for producing 6-alkoxy-(6h)-dibenz[c,e][1,2]-oxaphosphorines
08/28/2003WO2003070735A2 Components for producing amphoteric liposomes
08/28/2003WO2003070722A1 Improvement in the production of imidazole derivatives and novel intermediates of the derivatives
08/28/2003WO2003070717A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/28/2003WO2003070698A1 Process for preparation of carotenoids
08/28/2003WO2003070370A1 Process for the carbonylation of an ethylenically unsaturated compound and catalyst therefore
08/28/2003WO2003070169A2 Aminodiphosphonate apolipoprotein e modulators
08/28/2003WO2003069997A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
08/28/2003WO2002074293A3 Methods for restoring cognitive function following systemic stress
08/28/2003US20030163003 To form transition metal complexes which are used in such as asymmetric hydrogenation of imines, asymmetric hydride transfer reactions, hydrosilylation, hydroboration, hydrovinylation hydroformylation, allylic alkylation, etc.
08/28/2003US20030162994 For use in asymmetrical catalysis
08/28/2003US20030162988 Process for preparing dimethyl propanephoshonate
08/28/2003US20030162972 Pyridyl alkane acid amides as cytostatics and immunosupressives
08/28/2003US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/28/2003US20030162797 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/28/2003US20030162753 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans
08/28/2003CA2477191A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/27/2003EP1338602A1 Process for the preparation of dimethyl propanephosphonate
08/27/2003CN1439015A Phosphorus-containing hydroquinone derivatives, process for their production, phosphorus-containing epoxy resins make by using the derivatives, flame-retardant resin compositions, sealing media and
08/27/2003CN1438988A Use of compositions consisting of cations compounds and proton donors for stabilizing and/or separating nucleic acids or from micro-organism such as prokaryots, protozoa or algae
08/27/2003CN1438227A Novel phosphine ligand containing chiral four-membered ring base, its synthesizing method and use
08/27/2003CN1119310C Cyclo pentane-1,3-dione derivatives
08/26/2003US6610881 Method for producing sulfonated aryl phosphines
08/26/2003US6610875 Method for preparing chiral diphosphines
08/26/2003US6610858 Antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex; thrombolytic agents
08/26/2003US6610852 Prevent tissue damage; antidiabetic agents; Alzheimer's disease
08/26/2003US6610835 Compound of given formula; use for treatment of abnormal cell proliferation, tumors, inflammation, psoriasis, inflammatory bowel disease; promotion of cell differentiation, induction of apoptosis, inhibition of protein kinase C
08/26/2003US6610805 Catalyst ligands, catalytic metal complexes and processes using same
08/26/2003US6610743 Bicyclic metabotropic glutamate receptor ligands
08/26/2003US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof
08/26/2003US6610216 Multicolor photopolymerizable compound
08/23/2003CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/21/2003WO2003069961A1 Electroluminescent iridium compounds with phosphinoalkoxides and phenylpyridines or phenylpyrimidines and devices made with such compounds
08/21/2003WO2003069302A2 Alpha-substituted arylalkyl phosphonate derivatives
08/21/2003WO2003068786A1 Phosphine compounds
08/21/2003WO2003068785A1 Mono- and biacylphosphine derivatives
08/21/2003WO2003068784A2 Acyl- and bisacylphosphine derivatives
08/21/2003WO2003068783A1 Alkoxylated acyl- and bisacylphosphine derivatives
08/21/2003WO2003068719A2 Production of oxygenated products
08/21/2003WO2003068387A1 Oxidation catalyst and process for its preparation and process for oxidation using it
08/21/2003WO2003068242A1 Phospholipids as caspase inhibitor prodrugs
08/21/2003WO2003068240A1 Alpha-substituted heteroarylalkyl phosphonate derivattives
08/21/2003WO2002029001A3 Novel lysophosphatidic acid receptor agonists and antagonists
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158394 Phosphorus supported carbene transition metal complexes
08/21/2003US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/21/2003US20030158306 Phosphite additives in polyolefins
08/21/2003US20030158268 Neutralization of phosphate esters, compositions based upon and methods using same
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158191 Cannabinol derivatives
08/21/2003CA2476193A1 Electroluminescent iridium compounds with phosphinoalkoxides and phenylpyridines or phenylpyrimidines and devices made with such compounds
08/21/2003CA2476027A1 Alpha-substituted arylalkyl phosphonate derivatives
08/21/2003CA2475882A1 Alpha-substituted heteroarylalkyl phosphonate derivatives
08/20/2003EP1336614A1 Cyclic phosphazene compounds and use thereof as additives of perfluoropolyether oils
08/20/2003EP1336613A2 Metal complexes with iminohydroxamic acid as a ligand
08/20/2003EP1336325A1 Electroluminescent device
08/20/2003EP1335752A1 Multipurpose packages for sterilised products or products to be sterilised
08/20/2003EP1335726A1 Modified prodrug forms of ap/amp
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP0794786B1 The use of inositoltrisphosphate for the preparing of medicaments
08/20/2003CN1437611A 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives
08/20/2003CN1118503C Producing process for liquid preparation of tetraphenylphosphonium phenolate
08/20/2003CN1118458C Pyrimidinyl derivatives as interleukin inhibitors
08/20/2003CN1118457C Cyclic diamine compound and medicine containing the same
08/19/2003US6608230 Single-stage method for producing α-hydroxy ethers by oxidizing C=C unsaturated compounds with hydroperoxides
08/19/2003US6608212 Palladium catalyzed coupling of a vinylphosphate and aryl-metal halide; preparation of such as 1-(4-(2-(pyrrolidin-n-yl)-ethoxy)phenyl)-6-methoxy-3,4-dihydronaphthalene
08/19/2003US6608125 2-triethoxysilyl-1-ethyl thioacetate; tires
08/19/2003US6608122 Stabilized organic material
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608060 Treating inflammatory diseases, destructive bone disorders, reperfusion/ischemia in stroke, myocardial ischemia, renal ischemia, cardiac hypertrophy, rheumatoid arthritis, inflammatory bowel disease, or Crohn's disease
08/19/2003US6608046 β-lactamase and DD-peptidase inhibitors
08/19/2003US6608009 Phosphazene compounds and lubricants containing the same
08/19/2003US6607829 Tellurium-containing nanocrystalline materials
08/19/2003US6607710 Provide a bisphosphonic acid derivative and said bisphosphonic acid derivative being labeled with a radioactive nuclide, which has properties of rapid accumulation to the bone and rapid urinary excretion.
08/19/2003CA2089463C Process for stabilizing organophosphorus compounds
08/14/2003WO2003066643A1 Process for producing tertiary phosphine having bulky hydrocarbon group bonded
08/14/2003WO2003066642A1 Phosphorus chelate compounds
08/14/2003WO2003066548A2 Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003WO2003065882A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts